DE69415436D1 - Phosphonsäure diester-derivate - Google Patents

Phosphonsäure diester-derivate

Info

Publication number
DE69415436D1
DE69415436D1 DE69415436T DE69415436T DE69415436D1 DE 69415436 D1 DE69415436 D1 DE 69415436D1 DE 69415436 T DE69415436 T DE 69415436T DE 69415436 T DE69415436 T DE 69415436T DE 69415436 D1 DE69415436 D1 DE 69415436D1
Authority
DE
Germany
Prior art keywords
phenylated
lower alkyl
lower alkoxy
treating
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69415436T
Other languages
English (en)
Other versions
DE69415436T2 (de
Inventor
Yasuo Shinseibiru Shoji
Yoshihiko Tsuda
Kazuhiko Tsutsumi
Yasuhide Inoue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of DE69415436D1 publication Critical patent/DE69415436D1/de
Application granted granted Critical
Publication of DE69415436T2 publication Critical patent/DE69415436T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503Five-membered rings
    • C07F9/6506Five-membered rings having the nitrogen atoms in positions 1 and 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6536Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
    • C07F9/6539Five-membered rings
    • C07F9/6541Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69415436T 1993-02-15 1994-02-10 Phosphonsäure diester-derivate Expired - Fee Related DE69415436T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2573293 1993-02-15
PCT/JP1994/000209 WO1994018212A1 (en) 1993-02-15 1994-02-10 Phosphonic diester derivative

Publications (2)

Publication Number Publication Date
DE69415436D1 true DE69415436D1 (de) 1999-02-04
DE69415436T2 DE69415436T2 (de) 1999-06-02

Family

ID=12173991

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69415436T Expired - Fee Related DE69415436T2 (de) 1993-02-15 1994-02-10 Phosphonsäure diester-derivate

Country Status (13)

Country Link
US (1) US5480874A (de)
EP (1) EP0638581B1 (de)
JP (1) JP2926273B2 (de)
KR (1) KR100296163B1 (de)
CN (1) CN1046733C (de)
AT (1) ATE174923T1 (de)
AU (1) AU660125B2 (de)
CA (1) CA2118007C (de)
DE (1) DE69415436T2 (de)
DK (1) DK0638581T3 (de)
ES (1) ES2126097T3 (de)
TW (1) TW260664B (de)
WO (1) WO1994018212A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1070863C (zh) * 1995-12-27 2001-09-12 大塚制药工场株式会社 膦酸二酯衍生物
EP0970095B1 (de) * 1997-03-07 2003-10-29 Metabasis Therapeutics, Inc. Neue benzimidazol inhibitoren der fructose-1,6-bisphosphatase
AU6452098A (en) * 1997-03-07 1998-09-22 Metabasis Therapeutics, Inc. Novel purine inhibitors of fructose-1,6-bisphosphatase
US6340683B1 (en) 1999-04-22 2002-01-22 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (triazines)
PT1183245E (pt) 1999-04-22 2007-07-12 Lundbeck & Co As H Antagonistas selectivos de npy (y5)
US6218408B1 (en) 1999-06-30 2001-04-17 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (bicyclics)
US6989379B1 (en) 1999-04-22 2006-01-24 H. Lundbick A/S Selective NPY (Y5) antagonists
US6222040B1 (en) 1999-06-30 2001-04-24 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (tricyclics)
US6225330B1 (en) 1999-06-30 2001-05-01 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (tricyclics)
US6214853B1 (en) 1999-06-30 2001-04-10 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (bicyclics)
US7273880B2 (en) 1999-06-30 2007-09-25 H. Lunbeck A/S Selective NPY (Y5) antagonists
CA2458533C (en) 2001-10-09 2011-01-04 Tularik Inc. Imidazole derivates as anti-inflammatory agents
WO2003032916A2 (en) * 2001-10-16 2003-04-24 Structural Bioinformatics Inc. Organosulfur inhibitors of tyrosine phosphatases
AU2003207589B2 (en) 2002-01-16 2006-07-13 University Of Virginia Patent Foundation 2-Aminothiazole Allosteric Enhancers of A1 Adenosine Receptors
US20060135773A1 (en) * 2004-06-17 2006-06-22 Semple Joseph E Trisubstituted nitrogen modulators of tyrosine phosphatases
JP2008505916A (ja) * 2004-07-09 2008-02-28 メタバシス・セラピューティクス・インコーポレイテッド チロシンホスファターゼの酸素/窒素複素環阻害剤
NZ552650A (en) 2004-08-05 2010-09-30 Hoffmann La Roche Substituted N-acyl-2-aminothiazoles
WO2006028970A1 (en) 2004-09-02 2006-03-16 Cengent Therapeutics, Inc. Derivatives of thiazole and thiadiazole inhibitors of tyrosine phosphatases
BRPI0516557A (pt) * 2004-10-07 2008-09-09 Boehringer Ingelheim Int pi3 cinases
WO2006104030A1 (ja) * 2005-03-25 2006-10-05 Daiichi Sankyo Company, Limited チアゾール化合物
TW200712060A (en) * 2005-05-19 2007-04-01 Nissan Chemical Ind Ltd Thiophene compound having phosphoric ester and process for producing the same
US8779154B2 (en) * 2006-09-26 2014-07-15 Qinglin Che Fused ring compounds for inflammation and immune-related uses
DE102007012284A1 (de) 2007-03-16 2008-09-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel
DE102007035334A1 (de) * 2007-07-27 2009-01-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel
DE102007035333A1 (de) 2007-07-27 2009-01-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel
DE102007042154A1 (de) 2007-09-05 2009-03-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Arylsulfonylaminomethyphosphonsäure-Derivate, deren Herstellung und deren Verwendung als Arzneimittel
CN114681454B (zh) * 2022-03-17 2024-05-07 江南大学 噻唑类化合物在制备抗sars-cov-2新型冠状病毒药物中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU523040B2 (en) * 1978-05-15 1982-07-08 Kanebo Limited Calcium -antagonistic composition
US4434162A (en) * 1981-02-17 1984-02-28 Kanebo, Ltd. Phosphonic acid ester, pharmaceutical compositions containing the same and method of using the same
JPH0651625B2 (ja) * 1986-12-29 1994-07-06 株式会社大塚製薬工場 高脂質血症治療剤
US4822780A (en) * 1987-07-08 1989-04-18 Otsuka Pharmaceutical Factory, Inc. Carboxamide compounds
AU606808B2 (en) * 1988-06-29 1991-02-14 Otsuka Pharmaceutical Factory, Inc. Arylcarboxamide substituted by alkylphosphonates, process for preparing the same and a pharmaceutical composition containing the same
JPH0745508B2 (ja) * 1988-06-29 1995-05-17 株式会社大塚製薬工場 カルボン酸アミド誘導体
JP2584336B2 (ja) * 1989-05-30 1997-02-26 株式会社大塚製薬工場 カルボン酸アミド誘導体
WO1993023409A1 (en) * 1992-05-21 1993-11-25 Otsuka Pharmaceutical Factory, Inc. Phosphonic diester derivative

Also Published As

Publication number Publication date
EP0638581B1 (de) 1998-12-23
DK0638581T3 (da) 1999-08-23
EP0638581A4 (de) 1995-04-12
CN1046733C (zh) 1999-11-24
KR950700917A (ko) 1995-02-20
CA2118007A1 (en) 1994-08-18
KR100296163B1 (ko) 2001-11-05
ATE174923T1 (de) 1999-01-15
CA2118007C (en) 2003-12-02
WO1994018212A1 (en) 1994-08-18
AU660125B2 (en) 1995-06-08
US5480874A (en) 1996-01-02
DE69415436T2 (de) 1999-06-02
AU6010794A (en) 1994-08-29
ES2126097T3 (es) 1999-03-16
JP2926273B2 (ja) 1999-07-28
TW260664B (de) 1995-10-21
CN1102528A (zh) 1995-05-10
EP0638581A1 (de) 1995-02-15

Similar Documents

Publication Publication Date Title
DE69415436T2 (de) Phosphonsäure diester-derivate
ID24166A (id) Turunan piridazin baru dan obat-obatan yang mengandung hal yang sama sebagai ramuan efektif
DK0842661T3 (da) Anvendelse af estrogenagonister og -antagonister til fremstilling af et lægemiddel til behandling af atherosclerose, uafhængigt af lipidsænkning
ES2066000T3 (es) Compuestos derivados de pirimidinediona, metodo de produccion de los mismos y agentes antirritmicos que los contienen.
DK0771794T3 (da) Oxygenholdige heterocykliske forbindelser
DE69121996T2 (de) Fongizide Mittel
ATE225357T1 (de) Phosphonsaurediester-derivate
ATE499365T1 (de) Sulfamoyl-verbindungen und bakterizide für landwirtschaft oder gartenbau
DE69425804T2 (de) Phosphonsäurediesterderivate
MY113518A (en) Benzothiazolone derivatives
EP1000923A4 (de) Cyclopentenonderivate
PT99703A (pt) Processo para a preparacao de compostos 2-halo-3-substituido-5-arilpirrole insecticidas nematicidas e acaricidas
FI935823A0 (fi) Hypoglykemiska tiozolidindionfoereningar
DE3869194D1 (de) Fungizide.
ES2051856T3 (es) Procedimiento para la obtencion de agentes antiarritmicos de 1,2,3,4-tetrahidroisoquinolina.
DE69422793T2 (de) Phosphonsäurediester-derivat
TR199700266A2 (xx) Ariltiyo,-s�lfinil ve s�lfonil pirol ha�ere �ld�r�c� ajanlar�.
ES2077697T3 (es) Derivados de 1-fenoxicarbonil-2-pirrolidinona y agentes nootropicos.
ATE393149T1 (de) Insektizide dihydro-oxadiazine, -thiadiazine und -triazine

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee